These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18718724)

  • 1. Impact of glucocorticoids and chronic stress on progression of Parkinson's disease.
    Kibel A; Drenjancević-Perić I
    Med Hypotheses; 2008 Dec; 71(6):952-6. PubMed ID: 18718724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of Parkinson's disease.
    Lew M
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):155S-160S. PubMed ID: 18041935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research in motion: the enigma of Parkinson's disease pathology spread.
    Brundin P; Li JY; Holton JL; Lindvall O; Revesz T
    Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium ions in neuronal degeneration.
    Wojda U; Salinska E; Kuznicki J
    IUBMB Life; 2008 Sep; 60(9):575-90. PubMed ID: 18478527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's new? Clinical progression and staging of Parkinson's disease.
    Goetz CG
    J Neural Transm Suppl; 2006; (70):305-8. PubMed ID: 17017545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
    Verma R; Nehru B
    Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids. Mood, memory, and mechanisms.
    Wolkowitz OM; Burke H; Epel ES; Reus VI
    Ann N Y Acad Sci; 2009 Oct; 1179():19-40. PubMed ID: 19906230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The second brain and Parkinson's disease.
    Lebouvier T; Chaumette T; Paillusson S; Duyckaerts C; Bruley des Varannes S; Neunlist M; Derkinderen P
    Eur J Neurosci; 2009 Sep; 30(5):735-41. PubMed ID: 19712093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The experimental models of Parkinson's disease in animals].
    Grigor'ian GA; Bazian AS
    Usp Fiziol Nauk; 2007; 38(4):80-8. PubMed ID: 18064910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is hippocampal atrophy a future drug target?
    Dhikav V; Anand KS
    Med Hypotheses; 2007; 68(6):1300-6. PubMed ID: 17098374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide.
    Singh S; Dikshit M
    Brain Res Rev; 2007 Jun; 54(2):233-50. PubMed ID: 17408564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain in Parkinson's disease: Prevalence and characteristics.
    Beiske AG; Loge JH; Rønningen A; Svensson E
    Pain; 2009 Jan; 141(1-2):173-7. PubMed ID: 19100686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why do Alzheimer's disease and Parkinson's disease target the same neurons?
    Eggers AE
    Med Hypotheses; 2009 Jun; 72(6):698-700. PubMed ID: 19250756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender disparities in Parkinson's disease.
    Shulman LM; Bhat V
    Expert Rev Neurother; 2006 Mar; 6(3):407-16. PubMed ID: 16533144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in Huntington's and Parkinson's Disease.
    O'Keeffe GC; Michell AW; Barker RA
    Ann N Y Acad Sci; 2009 Oct; 1180():97-110. PubMed ID: 19906264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain atrophy and cognitive deficits in Cushing's disease.
    Patil CG; Lad SP; Katznelson L; Laws ER
    Neurosurg Focus; 2007; 23(3):E11. PubMed ID: 17961025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why have we failed to achieve neuroprotection in Parkinson's disease?
    Olanow CW; Kieburtz K; Schapira AH
    Ann Neurol; 2008 Dec; 64 Suppl 2():S101-10. PubMed ID: 19127580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redrawing Papez' circuit: a theory about how acute stress becomes chronic and causes disease.
    Eggers AE
    Med Hypotheses; 2007; 69(4):852-7. PubMed ID: 17376605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.